Health

Results: 277-288 of 9489

PR Newswire associated0

Thanks for all the txts: aql and parkrun Celebrate 13 Years of Impactful Tech Partnership Unlocking £10M in NHS Savings

SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend

Spire Healthcare announced as exclusive Team GB Official Healthcare Services Partner

Alkermes to Report Second Quarter Financial Results on July 28, 2026

More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026

PR Newswire associated0

Skyhawk Therapeutics Announces Expansion of its Global Pivotal FALCON-HD Clinical Trial for SKY-0515 in Huntington's Disease to the United States, Canada and the United Kingdom

PR Newswire associated0

The Bloc Strengthens European Creative Leadership to Drive Ambition and Impact Across Global Markets

Hologic’s Aptima® HPV Assay and Aptima Multitest Specimen Collection Kit

CE-IVDR Mark for Hologic’s Aptima® HPV Test Expanded to Include Self-Collected Sample Claim in Cervical Cancer Screening

Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

Neuraptive Therapeutics Licenses Innovative Bioresorbable Nerve Stimulation Technology from Washington University in St. Louis

PR Newswire associated0

Elsevier Foundation and The Lancet Announce Winners of Inaugural Evidence to Impact Awards

PR Newswire associated0

Newronika Receives CE Mark for αDBS®, Advancing Its Mission to Make Adaptive Therapy the Standard of Care